These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15637602)

  • 21. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 22. Too little, too late: when is the right time for new leadership in biotech?
    Branthwaite P; Williams SJ
    Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591
    [No Abstract]   [Full Text] [Related]  

  • 23. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 24. Start me up….
    Becker H
    Lab Chip; 2010 Dec; 10(23):3197-200. PubMed ID: 20976363
    [No Abstract]   [Full Text] [Related]  

  • 25. White biotech and the financial crisis.
    Rabinovich M
    Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
    [No Abstract]   [Full Text] [Related]  

  • 26. Hybrid rigor mortis.
    Nat Biotechnol; 2003 Jun; 21(6):585. PubMed ID: 12776128
    [No Abstract]   [Full Text] [Related]  

  • 27. Hybrid vigor.
    Williams K
    Nat Biotechnol; 2003 Aug; 21(8):843. PubMed ID: 12894189
    [No Abstract]   [Full Text] [Related]  

  • 28. Case study: India's billion dollar biotech.
    Chakma J; Masum H; Perampaladas K; Heys J; Singer PA
    Nat Biotechnol; 2010 Aug; 28(8):783. PubMed ID: 20697399
    [No Abstract]   [Full Text] [Related]  

  • 29. Funding assured for India's international biotechnology centre..
    Taylhardat AR; Falaschi A
    Nature; 2001 Jan; 409(6818):281. PubMed ID: 11201714
    [No Abstract]   [Full Text] [Related]  

  • 30. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 31. Rising biotech appetite in the East.
    Sheridan C
    Nat Biotechnol; 2006 Nov; 24(11):1305-6. PubMed ID: 17093459
    [No Abstract]   [Full Text] [Related]  

  • 32. Integrating intellectual property within the organizational social structure.
    Daizadeh I
    Nat Biotechnol; 2003 May; 21(5):573-5. PubMed ID: 12721578
    [No Abstract]   [Full Text] [Related]  

  • 33. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 34. India aims to become the main bioinformatics hub.
    Jayaraman KS; Louët S
    Nat Biotechnol; 2004 Aug; 22(8):933. PubMed ID: 15286632
    [No Abstract]   [Full Text] [Related]  

  • 35. Delisting threat looms large on biotech front.
    Lawrence S
    Nat Biotechnol; 2005 Jan; 23(1):5. PubMed ID: 15637598
    [No Abstract]   [Full Text] [Related]  

  • 36. Norway looks to biotech as the oil starts to run out.
    Hayhurst R
    Drug Discov Today; 2005 Mar; 10(6):387-90. PubMed ID: 15808817
    [No Abstract]   [Full Text] [Related]  

  • 37. NASD rule requires disclosure.
    Bouchie A
    Nat Biotechnol; 2001 Aug; 19(8):705. PubMed ID: 11491105
    [No Abstract]   [Full Text] [Related]  

  • 38. Syngenta ready to drop plans for Indian rice venture.
    Jayaraman KS
    Nature; 2002 Dec; 420(6916):596. PubMed ID: 12478254
    [No Abstract]   [Full Text] [Related]  

  • 39. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 40. Hercules and Kairos catalyze enzyme deal.
    Fox JL
    Nat Biotechnol; 1999 May; 17(5):417. PubMed ID: 10331785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.